Angiodynamics IncANGO
What Angiodynamics Inc does.
AngioDynamics is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing and selling products and technologies which aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. Our execution strategy is built on innovative R&D, clinical and regulatory pathway expansion and customer centric sales performance.
AngioDynamics was founded in Queensbury, N.Y., U.S., in 1988 and began manufacturing and shipping product in the early 1990s. The Company is headquartered in Latham, N.Y., with manufacturing primarily out of the Queensbury facility. Initially dedicated to the research and development of products used in interventional radiology, the Company soon became well established as a producer of diagnostic catheters for non-coronary angiography and thrombolytic delivery systems.
The Company grew over the following years as a result of acquisitions of companies including RITA Medical Systems in January 2007, Oncobionic in May 2008, the assets of Diomed in June 2008, Vortex Medical, Inc. in October 2012, the assets of Microsulis Medical Limited in January 2013, and Clinical Devices in August 2013. These acquisitions added product lines including ablation and NanoKnife systems, vascular access products, angiographic products and accessories, dialysis products, drainage products, thrombolytic products, embolization products and venous products. In May 2012, the Company acquired Navilyst Medical's Fluid Management business, which the Company sold in May 2019 to Medline Industries, Inc. pursuant to an asset purchase agreement.
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue | $291.0M | $316.2M | $338.8M | $303.9M | $292.5M | $320.2M |
| Net income | -$31.5M | -$26.5M | -$52.4M | -$184.3M | -$34.0M | -$36.7M |
| Free cash flow | $18.9M | -$11.5M | -$3.7M | -$30.7M | -$14.6M | $508,000 |
More on ANGO.
- Angiodynamics Inc summary
- Angiodynamics Inc financial statements
- Angiodynamics Inc key metrics
- Angiodynamics Inc health scores and style box
- Angiodynamics Inc earnings
- Angiodynamics Inc dividends
- Angiodynamics Inc valuation
- Angiodynamics Inc ownership and insiders
- Angiodynamics Inc peers
Figures from Angiodynamics Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.